On-demand fully customizable drug tablets via 3D printing technology for personalized medicine.

Personalized medicine should ideally be prescribed to every individual because of the unique characteristics (e.g., biological, physical, and medical) of each individual. It is, however, challenging to provide personalized medicine for the mass population of specific individuals effectively and efficiently. This manuscript describes a method of fabricating fully customizable drug tablets for personalized medicine by the 3D printing technology. This method involves the versatile fabrication of the tablets via the specifically designed 3D printed molds of different shapes and sizes, and an intuitive 1-dimensional release of drug that relates the shape of the drug-containing matrix to the release profile. The customization includes all the aspects of varying dosage, duration, release profiles, and combination of multiple drugs. In particular, it has previously been technically difficult to devise a single platform that fabricates carriers that release drug with any desired type of release profiles. This method of fabricating fully customizable tablets is simple, inexpensive, and efficient. Detailed selection and investigation of the materials ensured that the tablet and the method of fabrication are safe (e.g., biocompatible, FDA-approved ingredients used) and other desirable features (e.g., sustained release and high dosage) are achieved. These desirable characteristics of the method thus allow fully customizable drug tablets to be fabricated efficiently on the spot after the diagnosis of individual patients; at the same time, the method can be made widely accessible to the mass population. Hence, the concept of personalized medicine can truly be realized.

[1]  Gero Decher,et al.  Self‐Assembled Smart Nanocarriers for Targeted Drug Delivery , 2016, Advanced materials.

[2]  Stefaan C. De Smedt,et al.  “Programmed Polymeric Devices” for Pulsed Drug Delivery , 2004, Pharmaceutical Research.

[3]  E. Ashley Towards precision medicine , 2016, Nature Reviews Genetics.

[4]  H. Takeuchi,et al.  Solventless dry powder coating for sustained drug release using mechanochemical treatment based on the tri-component system of acetaminophen, carnauba wax and glidant , 2013, Drug development and industrial pharmacy.

[5]  J. Grenier,et al.  Melanocyte Stem Cell Activation and Translocation Initiate Cutaneous Melanoma in Response to UV Exposure. , 2017, Cell stem cell.

[6]  P. Dario,et al.  Capsule endoscopy: progress update and challenges ahead , 2009, Nature Reviews Gastroenterology &Hepatology.

[7]  F. Buttgereit,et al.  Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial , 2008, The Lancet.

[8]  P. Marcellin,et al.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. , 2004, Annals of internal medicine.

[9]  R. Horwitz,et al.  (De)Personalized Medicine , 2013, Science.

[10]  Stephen Kennedy,et al.  Pulsatile Chemotherapeutic Delivery Profiles Using Magnetically Responsive Hydrogels , 2018, ACS biomaterials science & engineering.

[11]  M. Khan,et al.  A new chapter in pharmaceutical manufacturing: 3D‐printed drug products☆, ☆☆ , 2017, Advanced drug delivery reviews.

[12]  Zhi-wei Ma,et al.  Chitosan cross-linked with poly(ethylene glycol)dialdehyde via reductive amination as effective controlled release carriers for oral protein drug delivery. , 2017, Bioorganic & medicinal chemistry letters.

[13]  Natalia A. Agudelo,et al.  PEGylation of PLA nanoparticles to improve mucus-penetration and colloidal stability for oral delivery systems , 2016 .

[14]  R. Jirtle,et al.  Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.

[15]  Han Wei Hou,et al.  Rapid purification of sub-micrometer particles for enhanced drug release and microvesicles isolation , 2017 .

[16]  F. Collins,et al.  The path to personalized medicine. , 2010, The New England journal of medicine.

[17]  M. Rowbotham,et al.  Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study , 2004, Pain.

[18]  Ronald A. Siegel,et al.  Fundamentals and Applications of Controlled Release Drug Delivery , 2012, Advances in Delivery Science and Technology.

[19]  Simon Gaisford,et al.  3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics. , 2015, Molecular pharmaceutics.

[20]  K. Fukushige,et al.  Defined drug release from 3D‐printed composite tablets consisting of drug‐loaded polyvinylalcohol and a water‐soluble or water‐insoluble polymer filler , 2018, International journal of pharmaceutics.

[21]  B. Anderson,et al.  Cancer in global health: How do prevention and early detection strategies relate? , 2015, Science Translational Medicine.